A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2

Name: A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2
Published: 2012
License: Public Domain

ASLAN Pharmaceuticals · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

gastric-cancer

stomach neoplasms, cancer of stomach, cancer of the stomach, gastric cancer, gastric neoplasms, metastatic gastro-oesophageal carcinoma, recurrent gastro-oesophageal carcinoma, her-1, her-2, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Clinical Trial Evaluating the Effect of ASLAN001 in Patients With Recurrent/Metastatic Gastric Cancer Whose Tumors Are Either HER-2 Amplified or Co-expressing HER-1 and HER-2

Related documents